0001638599-17-000178.txt : 20170210
0001638599-17-000178.hdr.sgml : 20170210
20170210160513
ACCESSION NUMBER: 0001638599-17-000178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170208
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBANY MOLECULAR RESEARCH INC
CENTRAL INDEX KEY: 0001065087
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 141742717
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 CORPORATE CIRCLE
STREET 2: P O BOX 15098
CITY: ALBANY
STATE: NY
ZIP: 12203-5154
BUSINESS PHONE: 5184640279
MAIL ADDRESS:
STREET 1: 21 CORPORATE CIRCLE
STREET 2: P O BOX 15098
CITY: ALBANY
STATE: NY
ZIP: 12203-5154
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gutierrez Fuentes Luis Gerardo
CENTRAL INDEX KEY: 0001647975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35622
FILM NUMBER: 17593212
MAIL ADDRESS:
STREET 1: C/O ALBANY MOLECULAR RESEARCH, INC.
STREET 2: 26 CORPORATE CIRCLE
CITY: ALBANY
STATE: NY
ZIP: 02203
FORMER NAME:
FORMER CONFORMED NAME: Gutierrez Fuentez Luis Gerardo
DATE OF NAME CHANGE: 20150720
FORMER NAME:
FORMER CONFORMED NAME: Fuentes Luis Gerardo Gutierrez
DATE OF NAME CHANGE: 20150713
4
1
doc4_4519.xml
PRIMARY DOCUMENT
X0306
4
2017-02-08
0
0001065087
ALBANY MOLECULAR RESEARCH INC
AMRI
0001647975
Gutierrez Fuentes Luis Gerardo
C/O ALBANY MOLECULAR RESEARCH, INC.
26 CORPORATE CIRCLE
ALBANY
NY
12212
1
0
0
0
Common Stock
2017-02-08
4
A
0
3802
0
A
6656
D
Common Stock
2200000
I
See Footnote
Option to Purchase Common Stock
18.41
2017-02-08
4
A
0
9358
0
A
2027-02-08
Common Stock
9358
9358
D
These shares are held directly by 3-Gutinver, S.L., a company organized and existing under the laws of Spain. The Reporting Person is the Sole Administrator of 3-Gutinver, S.L. and may be deemed to beneficially hold these securities in such capacity. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed and admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or any other purpose.
Option is exercisable as to 1/3rd of the shares annually on the anniversary date of the grant for each of the next three years.
/s/Lori M. Henderson, attorney-in-fact
2017-02-10